Clinical Profile and Predictors of Outcome in Children with Acute Fulminant Myocarditis Receiving Intensive Care: A

Muralidharan Jayashree1, Manisha Patil1, Govindappa Benakatti2

  • 1Division of Pediatric Emergency and Intensive Care, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Insights

Acute fulminant myocarditis in children is serious, but intravenous immunoglobulin (IVIG) treatment may improve survival. Multiorgan dysfunction independently predicts mortality in these critical pediatric cases.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Immunology

Background:

  • Acute myocarditis in children presents significant morbidity and mortality risks.
  • Limited data exists on the efficacy of intravenous immunoglobulin (IVIG) for pediatric acute fulminant myocarditis (AFM).

Purpose of the Study:

  • To analyze the clinical and treatment profiles of children with AFM.
  • To identify predictors of outcome in pediatric AFM patients requiring intensive care.
  • To evaluate the impact of IVIG on survival in this population.

Main Methods:

  • Retrospective analysis of 120 children diagnosed with acute myocarditis between 2008 and 2018.
  • Detailed review of clinical data, treatment interventions, and outcomes.
  • Statistical analysis to identify factors associated with mortality and survival benefit.

Main Results:

  • AFM affected 89 children, with 60.7% presenting with hypotension and a median ejection fraction of 25%.
  • Mechanical ventilation (59.2%) and inotropic support (74.2%) were common intensive care interventions.
  • Mortality was 17.5%, with fever, shock, acidosis, AKI, transaminitis, and multiorgan dysfunction syndrome (MODS) predicting poor outcomes.
  • IVIG treatment was associated with significantly lower mortality (12.1% vs. 28.9%).

Conclusions:

  • MODS is an independent predictor of mortality in pediatric AFM.
  • IVIG treatment demonstrates a survival benefit in children with AFM.
  • Aggressive management of complications like MODS is crucial for improving prognosis in pediatric AFM.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
22
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
14
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
78
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
25